FARE | Food Allergy Research & Education ✓

@FoodAllergy · McLean, VA · joined 01 Apr 2009

FARE is the largest US nonprofit organization dedicated to driving research and a cure for the more then 33 million people in the US with food allergies

23 209Followers

997Following

12 610Posts total

3.5KViews on collected posts

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views812this account1 456median for 10K–100K

Reach, %3.50%this account4.50%median for 10K–100K

Engagement, %0.85%this account1.88%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	812	1 456	0.56×
Reach (views ÷ followers)	3.50%	4.50%	0.78×
Engagement rate	0.85%	1.88%	0.45×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

82216 Aug

84717 Aug

81223 Aug

49225 Aug

49228 Aug

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.85%16 Aug

1.42%17 Aug

0.86%23 Aug

0.20%25 Aug

0.20%28 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.88%.

What the audience does

Likes71.9%23 in total

Reposts9.4%3 in total

Replies6.2%2 in total

Bookmarks12.5%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Latest posts

For the more than 470,000 people in the U.S. living with EoE, we wanted to share some encouraging news. Newly announced Phase 3 results for tezepelumab-ekko showed improvements in swallowing symptoms and other signs of the disease. Read more about the phase 3 trial results here: 492 views · 1 likes · 0 reposts · 0 replies 28 Aug 2026 This past weekend, the food allergy community came together for FARE's Regional Summit: Real Talk. Real Solutions. at Stanford University for a full day of learning, connection, and conversation. Caregivers, adults living with food allergies, tweens, and teens joined leading htt 492 views · 1 likes · 0 reposts · 0 replies 25 Aug 2026 "When we prepared for our first child, it never crossed our minds that food allergies might become part of our story. At six months old, we gave our daughter, Eliza, peanut butter for the first time. Within minutes, she broke out in hives from head to toe. We were completely http 812 views · 6 likes · 0 reposts · 1 replies 23 Aug 2026 Every neffy (epinephrine nasal spray) prescription will now include a carry case at no additional cost to patients. The new case is designed to make neffy easier to carry and keep readily accessible wherever you go. Patients may begin seeing the updated packaging at pharmacies as 847 views · 9 likes · 2 reposts · 1 replies 17 Aug 2026 "For three frustrating years, I suffered from unexplained health issues without a diagnosis. I bounced from doctor to doctor and was misdiagnosed with conditions like eosinophilic esophagitis before finally getting answers. Thanks to the brilliant expertise of Dr. Anne Marie http 822 views · 6 likes · 1 reposts · 0 replies 16 Aug 2026